COMPANY
SI-BONE
FDA-cleared device company Clinical Phase 3
Timeline
- FDA FDA 510(k) clearance: iFuse Granite Onyx Implant System — K262067, Sep 23, 2026. Applicant at approval: SI-BONE, Inc. source ↗
- Trial start —: Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes source ↗
- Trial start —: Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures source ↗
- FDA FDA 510(k) clearance: iFuse INTRA Ti Implant System — K253488, Feb 11, 2026. Applicant at approval: SI-BONE, Inc. source ↗
- FDA FDA 510(k) clearance: iFuse Bedrock Granite Implant System — K253094, Oct 9, 2025. Applicant at approval: SI-BONE, Inc. source ↗
- FDA FDA 510(k) clearance: iGPS Navigation Instruments — K251780, Sep 15, 2025. Applicant at approval: SI-BONE, Inc. source ↗
- Trial start —: Innovative Spinopelvic Solutions With Real-World Evidence source ↗
- Trial start —: Pelvic Fixation and Fusion During Multilevel Spinal Surgery source ↗
- Trial start Phase 4: iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction source ↗
- Trial start Not phased (device or behavioral study): Sacral Fracture Fusion/Fixation for Rapid Rehabilitation source ↗
- Trial start Not phased (device or behavioral study): SI Joint Stabilization in Long Fusion to the Pelvis source ↗
- Trial start Not phased (device or behavioral study): Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants source ↗
- Trial start —: LOIS: Long-Term Follow-Up in INSITE/SIFI source ↗
- Trial start Not phased (device or behavioral study): iFuse Implant System® Minimally Invasive Arthrodesis source ↗
- Trial start Phase 4: Validity and Reliability of Diagnostic Findings of SI Joint Blocking source ↗
- Trial start Not phased (device or behavioral study): Investigation of Sacroiliac Fusion Treatment (INSITE) source ↗
- Trial start —: Sacroiliac Joint Fusion With iFuse Implant System (SIFI) source ↗
Upcoming milestones
- 2027-11 (ESTIMATED) · · Pelvic Fixation and Fusion During Multilevel Spinal Surgery · NCT05640908
- 2028-02 (ESTIMATED) · · Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures · NCT07530497
- 2028-03 (ESTIMATED) · · Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes · NCT07565545
- 2034-12 (ESTIMATED) · · Innovative Spinopelvic Solutions With Real-World Evidence · NCT06706908
Clinical trials (lead sponsor) 13
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07530497 | Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures | Not listed | Recruiting | 2026-08 | 2028-02 (estimated) |
| NCT05870488 | iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction | Phase 4 | Active, not recruiting | May 23, 2023 | Apr 23, 2025 (actual) |
| NCT07565545 | Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes | Not listed | Not yet recruiting | 2026-09 | 2028-03 (estimated) |
| NCT06706908 | Innovative Spinopelvic Solutions With Real-World Evidence | Not listed | Active, not recruiting | Dec 15, 2024 | 2034-12 (estimated) |
| NCT05640908 | Pelvic Fixation and Fusion During Multilevel Spinal Surgery | Not listed | Active, not recruiting | Jun 5, 2023 | 2027-11 (estimated) |
| NCT03122899 | Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants | Not phased (device or behavioral study) | Completed | Oct 3, 2017 | Jun 19, 2024 (actual) |
| NCT04062630 | SI Joint Stabilization in Long Fusion to the Pelvis | Not phased (device or behavioral study) | Completed | May 20, 2020 | Dec 17, 2024 (actual) |
| NCT05426356 | Sacral Fracture Fusion/Fixation for Rapid Rehabilitation | Not phased (device or behavioral study) | Terminated | Sep 18, 2022 | Jun 15, 2024 (actual) |
| NCT01874236 | Validity and Reliability of Diagnostic Findings of SI Joint Blocking | Phase 4 | Terminated | Apr 22, 2013 | Sep 30, 2014 (actual) |
| NCT02270203 | LOIS: Long-Term Follow-Up in INSITE/SIFI | Not listed | Completed | 2014-10 | 2019-07 (actual) |
| NCT01741025 | iFuse Implant System® Minimally Invasive Arthrodesis | Not phased (device or behavioral study) | Completed | 2013-06 | Dec 15, 2015 (actual) |
| NCT01681004 | Investigation of Sacroiliac Fusion Treatment (INSITE) | Not phased (device or behavioral study) | Completed | 2012-09 | 2015-02 (actual) |
| NCT01640353 | Sacroiliac Joint Fusion With iFuse Implant System (SIFI) | Not listed | Completed | 2012-07 | 2015-01 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: iFuse Granite Onyx Implant System — K262067, Sep 23, 2026. Applicant at approval: SI-BONE, Inc. source ↗
- FDA 510(k) clearance: iFuse INTRA Ti Implant System — K253488, Feb 11, 2026. Applicant at approval: SI-BONE, Inc. source ↗
- FDA 510(k) clearance: iFuse Bedrock Granite Implant System — K253094, Oct 9, 2025. Applicant at approval: SI-BONE, Inc. source ↗
- FDA 510(k) clearance: iGPS Navigation Instruments — K251780, Sep 15, 2025. Applicant at approval: SI-BONE, Inc. source ↗